Literature DB >> 25998968

Phenytoin toxicity in two-month-old Thai infant with CYP2C9 gene polymorphism--A case report.

Montida Veeravigrom1, Vorapol Jaroonvanichkul2, Wiracha Netbaramee3, Pichaya Phaisarn3, Thanita Uyathanarat3.   

Abstract

Phenytoin is one of the most well established and most effective antiepileptic medications for the treatment of focal seizures. In our clinical practice, it has proven difficult to maintain therapeutic phenytoin levels in infants less than three months of age. Incidence of phenytoin toxicity in infants is very rare. The cytochrome P450 super family plays an important role in phenytoin metabolism, especially CYP2C9 and CYP2C19. In this case report, we profiled a two-month-old Thai infant who developed phenytoin toxicity resulting from CYP2C9 gene polymorphism.
Copyright © 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CYP2C9 gene polymorphism; Infant; Phenytoin toxicity

Mesh:

Substances:

Year:  2015        PMID: 25998968     DOI: 10.1016/j.braindev.2015.05.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

1.  Cardiac Collapse Secondary to Phenytoin Toxicity in a Neonate Treated with Extracorporeal Membrane Oxygenation Support (ECMO).

Authors:  Michelle Knecht; Joseph LaRochelle; Brian Barkemeyer; Raegan Gupta; Michael Brumund; Christy Mumphrey
Journal:  J Med Toxicol       Date:  2019-11-26

Review 2.  The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review.

Authors:  Nadir Yalçin; Robert B Flint; Ron H N van Schaik; Sinno H P Simons; Karel Allegaert
Journal:  Pharmgenomics Pers Med       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.